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Abstract
Long term studies of childhood cancer survivors are hampered by difficulties in tracking young adult
participants. After performing a National Death Index (NDI) search we sought to identify which
factors best predicted a match among known decedents from the National Wilms Tumor Study
(NWTS) and to determine if record linkage could substitute for missing follow-up in a cohort of
NWTS survivors. To our knowledge, this is the first study to compare passive mortality follow-up
using the NDI to active follow-up of a childhood and young adult population.
Records for 984 known decedents and 3,406 subjects whose January 1, 2002 vital status was
unknown were sent to the NDI in June 2003. In April 2005 NWTS follow-up records were used
to reassess January 1, 2002 vital status. Matches were established for 709 of 789 known decedents
(sensitivity 89.9%) with a date of death between 1979 and 2001, the calendar period covered by
the NDI at the time of the search. No matches were identified among 1,052 subjects known to be
alive in 2002 (specificity 100%). Factors associated with decreased sensitivity were an unknown
social security number (sensitivity 87.8%), Hispanic ethnicity (76.4%) and foreign birth (56.5%). For
2,351 subjects with 2002 vital status unknown who had 13,166 pre 2002 person-years of missing
observation, only 18 deaths were ascertained by the NDI whereas 79.3 were expected based on
NWTS mortality data. Mortality analyses based strictly on NDI search results and those based on
NWTS follow-up augmented with NDI search results yielded inflated estimates of the 15 year
survival rate when compared with estimates based on NWTS active follow-up.
Match rates were comparable to those observed in adult populations. Since the same selection
factors were likely associated with NDI failure to match and NWTS loss to follow-up, use of the
NDI to fill in missing follow-up data appears unwarranted.
Introduction
The remarkable progress in treatment of childhood cancer
during the past few decades has focused attention on the
health status of the growing population of survivors [1-3].
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Such research is hampered, however, by difficulties in
locating teenage and adult survivors and by their reluc-
tance to return to pediatric hospitals [4]. Studies that
actively follow participants by repeated contact are subject
to drop-out that may differentially affect particular sub-
groups, e.g., underprivileged minorities [5]. Although sta-
tistical methods adjust for such loss in estimating
population mortality rates, serious bias may result if sub-
jects who drop out differ in health status from those who
remain on study [6,7]. Studies that maintain passive fol-
low-up by linkage of clinical records to disease or mortal-
ity registries are likewise subject to bias from failure of
matching algorithms or events that occur outside the juris-
diction of the registry [8].
The National Death Index (NDI) is a centralized registry
maintained by the National Center for Health Statistics of
all deaths that occurred in the United States, Puerto Rico,
and the Virgin Islands since 1979 [9]. Record linkage
through the NDI has been well tested in adult populations
[8] and is now commonly used to study death rates in
adult cohorts [10-14]. The NDI has also been used to
ascertain mortality in cohorts of children and young
adults [15-17] but a literature search revealed no system-
atic evaluation of its use in these populations. In addition,
no previous work was found evaluating the NDI as a
means of augmenting follow-up in a study that attempts
to maintain active contact with all participants.
Our study compared mortality ascertainment via active
follow-up of a large cohort of subjects with childhood kid-
ney cancer to mortality ascertainment using record link-
age to the NDI. There were two specific aims: first, to
identify which factors best predicted an NDI match
among known decedents; and second, to determine how
well information from the NDI search might substitute for
missing follow-up data for those alive at last contact, but
lost to follow-up before the closing date, in an attempt to
improve the accuracy of mortality estimates.
Analysis
Study population
Between 1969 and 1995, medical institutions in the US
and Canada enrolled 6,618 children with renal neo-
plasms on one of four randomized clinical trials con-
ducted by the National Wilms Tumor Study (NWTS)
Group [18-21]. Nearly 95 percent of enrollees had Wilms
tumor while the remainder had clear cell sarcoma
(CCSK), rhabdoid tumor of the kidney (RTK) or other rare
histologic variants [22]. From the outset the NWTS
emphasized continued follow-up of surviving participants
as part of a late effects study to increase understanding of
the long-term effects of diagnosis and treatment on devel-
opment of second malignant neoplasms, congestive heart
failure, renal failure and adverse pregnancy outcomes [23-
26].
Follow-up is rigorously pursued for all on-study partici-
pants. Data requests are sent annually to the institution
where the subject received treatment, for subjects still
returning there, or otherwise directly to participants or a
designated family member. When the most recent record
for any subject is more than two years out-of-date, the
computer system flags the case for immediate action. If
the subject is not returning to the institution for follow-
up, the NWTS requests authorization to track the partici-
pant in order to reestablish annual contact directly. If the
NWTS discovers that a participant already in direct contact
has moved, aggressive tracking is initiated to locate and
renew contact with the participant.
The cohort for the present investigation comprised the
6,217 subjects enrolled from US institutions. By June,
2003, 198 were known to have died prior to January 1,
1979; 786 were known to have died after 1978 but prior
to January 1, 2002, the closing date of the study; 1,827
were known to be alive on the closing date; and 3,406 had
vital status unknown. Available identifying information
for the 984 known decedents and for the 3,406 with vital
status unknown was submitted to the NDI, which at the
time of submission in June 2003 had collected data on
deaths occurring in the US from 1979 through 2001.
The NWTS clinical trial protocols were approved by the
Institutional Review Board (IRB) of the Fred Hutchinson
Cancer Research Center and by the IRB of each participat-
ing institution. Each subject, or in the vast majority of
cases their parent/guardian, provided informed consent at
the time of enrollment. At age 18 each subject was con-
tacted and asked to provide their own informed consent
for continued participation as an adult.
National death index search
Details of the NDI matching procedure have been dis-
cussed in detail elsewhere [9,27]. Multiple potential NDI
record matches are frequently identified for a single sub-
mitted user record. It is the investigator's responsibility to
assess match quality and to make the final determination
of match status. Briefly, in the cohort of known decedents
all exact matches, where the NDI and NWTS records
matched on all available identifiers, were accepted. For
the remaining decedents and for subjects with vital status
unknown potential matches assigned a suitably high score
by the NDI [27] or which we determined to be of interest
were assessed manually. This involved searching the sub-
ject's chart for information bearing on the validity of the
potential match. For example, we compared the NDI
recorded state of death with the state(s) where the subjectEpidemiologic Perspectives & Innovations 2007, 4:5 http://www.epi-perspectives.com/content/4/1/5
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resided or was treated and checked for coding errors that
might explain discrepancies in date of birth or SSN.
Statistical analysis
Vital status on January 1, 2002 was updated from NWTS
follow-up records in April, 2005. The updated cohort of
subjects known to have died between 1979 and 2001 was
used to determine which of the following factors were
associated with an NDI match: sex, ethnicity (non-His-
panic Caucasian, African American, Asian, Hispanic,
unknown/other), Social Security Number (SSN) on file,
year of death, country of birth (United States (US), foreign
or unknown), age at death, geographic location of treat-
ment institution (northern border, southern border, non-
border state), institutional compliance (the fraction of
cases from the registering institution in active follow-up)
and NWTS recorded cause of death (tumor, toxicity or
infection, toxicity with viable tumor present, other/
unknown). Each factor was examined separately and then
all were examined together using multiple logistic regres-
sion. Records submitted to the NDI due to unknown sur-
vival status as of June 2003, but which when updated in
2005 showed survival beyond that date, were used to
assess the specificity of the NDI matches.
Survival estimates based on information acquired
through standard NWTS follow-up procedures were com-
pared with those based on NWTS follow-up augmented
with results from the NDI search. All analyses used a clos-
ing date of January 1, 2002. Deaths prior to 1979 were
included in the analyses so as to be consistent with other
reports from the NWTS and provide accurate overall sur-
vival estimates. All survival analyses were stratified by
NWTS study number into the "early" era (NWTS-1,2) and
"modern" era (NWTS-3,4) to account for changes in sur-
vival which occurred mainly due to substantial therapeu-
tic advances made over the course of the clinical trials. For
the standard analysis, which used only the updated 2005
NWTS information, subjects lost to follow-up before the
closing date had their records censored. For the aug-
mented analysis, subjects last known alive prior to closing
who had no NDI match had their date last seen updated
to January 1, 2002, whereas those who had a match were
considered to have died on the date supplied by the NDI.
Because we did not submit the entire NWTS cohort to the
NDI we could not directly compare the results of a mor-
tality study using an NDI search alone with mortality
based on active follow-up through the NWTS. As a repre-
sentation of what might have happened had the NWTS
halted follow-up and relied solely on the NDI results, a
third analysis was preformed in which subjects known to
the NWTS to have died after 1978 but who were not
matched through the NDI were considered to have been
alive on January 1, 2002. For all analyses, overall survival
percentages and 95 percent Confidence Intervals (CIs)
were estimated at 15 years from diagnosis by actuarial
methods [7,28].
Actuarial methods were also used to calculate 10 year per-
centages and 95% CIs of loss to follow-up by the NWTS
among subjects enrolled prior to January 1, 1990. The pol-
icy of the NWTS is to start tracking procedures once a sub-
ject has been out of contact for two years. The selection of
a cut-off date twelve years prior to the study closing date
allows each subject to have had the potential for at least
ten years of follow-up.
To determine how well passive follow-up through the
NDI could substitute for active follow-up, the number of
deaths ascertained through the NDI search was compared
with an expected number based on NWTS mortality rates.
The entire cohort of 6,217 subjects was used to determine
numbers of deaths and person-years of follow-up by age,
time since diagnosis, gender, study number (NWTS-1-4),
stage of disease (I-V), histology (favorable or anaplastic
Wilms tumor, CCSK, RTK or other) and the availability of
an SSN. The Lexis package [29] developed for the R statis-
tical [30] was used to form the seven dimensional tables.
Mortality rates were calculated by dividing numbers of
deaths by person-years of follow-up in each cell of the
table. For subjects who had their follow-up augmented by
the NDI, i.e. those who in June 2005 were still last known
to be alive prior to closing and for whom no NDI match
was found, a similar table was constructed of augmented
person-years at risk from the later of date last seen or Jan-
uary 1, 1979 to closing. Multiplying the mortality rates for
the entire cohort by the augmented person-years gave the
expected number of deaths in each cell. Observed and
expected mortality rates for this period of augmented fol-
low-up were compared by availability of a SSN and other
factors. Poisson based p-values for testing whether the
observed number of deaths could be adequately
explained by expected mortality rates were calculated
using Byar's approximation as described by Breslow and
Day [31].
Results
A total of 706 NDI matches were established among the
786 subjects known as of June, 2003 to have died between
1979 and 2001. No NDI matches were identified in the
group of known decedents with deaths prior to 1979. A
further 21 matches were identified from the cohort of
3,406 NWTS subjects with vital status unknown on Janu-
ary 1, 2002. Three of these deaths were also ascertained in
April 2005 when NTWS follow-up was used to update
records of the 3,406 subjects whose vital status was
unknown at the time of the NDI submission. Thus the
NDI record search matched 709 of the 789 deaths (89.8
percent) known by the NWTS to have occurred betweenEpidemiologic Perspectives & Innovations 2007, 4:5 http://www.epi-perspectives.com/content/4/1/5
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1979 and closing. After the 2005 update, 1,052 subjects
with vital status previously unknown were found to have
survived into 2002 or beyond. No NDI matches were
identified among these 1,052 subjects giving a match spe-
cificity of 100 percent. A full breakdown of the cohort by
January 1, 2002 vital status as assessed in June 2003 and
again in April 2005, with ascertainment of deaths by the
NDI and the NWTS is given in Figure 1. A further cross-
tabulation of NDI match status by January 1, 2002 vital
status is shown in Table 1. The individual with unknown
vital status whose record was not sent to the NDI had a
recorded date last seen that changed from after January 1,
2002 to before that date during the mortality update.
Table 2 shows match rates for the 789 known decedents.
Using multiple logistic regression, three factors were inde-
pendently associated with a lowered match rate: lack of
SSN, Hispanic ethnicity and birth outside the US. Sensitiv-
ity was 96.7 percent for subjects with an SSN on file but
only 87.8 percent for those without. Sensitivities were also
substantially lower for Hispanics (76.4 percent) and for
those born abroad (56.5 percent) compared to those of
non-Hispanic Caucasians and US born, respectively. Sub-
jects who died during earlier calendar periods were also
less likely to have a match, but year of death was not a sta-
tistically significant factor after adjustment for the con-
founding effects of SSN. Age at death was not significantly
associated with the probability of having a match. This
was true when age at death was included as a continuous
variable (p = 0.16) or as a grouped linear variable (p =
0.08).
Results of the survival analyses comparing standard
NWTS, NDI supplemented and NDI only follow-up are
presented in Table 3. These are presented separately for
the "early" (NWTS-1,2) and "modern" (NWTS-3,4) treat-
ment eras. After augmenting the NWTS data with NDI
search results, 2,351 subjects with vital status unknown
on closing had an average of 5.6 years of follow-up added
to their records between 1979 and 2001 for a total of
13,166 person-years. Eighteen deaths based on the NDI
match were added to the 198 pre- and 789 post-1979
deaths ascertained by the NWTS. The NDI augmentation
led to small increases in each of the actuarial survival esti-
mates.
Since the actuarial procedure for the augmented data
increased the date last seen to January 1, 2002 for all sur-
viving subjects, but increased the numbers of deaths only
by those that occurred after 1978, part of the apparent
increase in survival was due to failure to account for
deaths before 1979 in subjects lost to follow-up earlier.
However, only 43 person-years of follow-up, during
which 2.3 deaths would have been expected, were added
to the pre-1979 period as a result of the NDI search. Con-
sequently, any bias caused by the gap before the NDI
became operational would be minimal.
The NDI only analysis removed 80 deaths, added in a
total of 1,170 person-years of follow-up for these 80 sub-
jects and resulted in additional increases in the survival
estimates. The improvement in survival from the first two
NWTS trials to the second two is apparent no matter
which death ascertainment method is used.
Among the 2,351 subjects whose follow-up was aug-
mented by NDI search data we would have expected 79.3
deaths between 1979 and 2001 based on NWTS mortality
rates. This is 4.4 fold higher than the 18 additional deaths
actually found. SSNs were available for 23 percent of
known decedents and 58 percent of subjects with an
unknown vital status. The NDI search identified 6/12.1
(50 percent) of the deaths expected among participants
with an SSN but only 12/67.3 (18 percent) of the deaths
expected among those without. The difference between
observed and expected deaths was not statistically signifi-
cant among participants with an SSN (p = 0.09) but was
among those without an SSN (p < 0.001).
Participants of non-Hispanic Caucasian ethnicity and
those born in the United States had much better follow-
up rates than children of other ethnicities and places of
birth. By 10 years after enrollment 9.5 percent [95% CI:
(8.5, 10.7)] of non-Hispanic Caucasian participants were
lost to follow-up while 22.4 percent (19.5, 25.8) of Afri-
can American, 19.5 percent (10.2, 35.4) of Asian and 25.9
percent (21.2, 31.4) of Hispanic participants had been
lost. Of participants born in the US, 12.2 percent (11.1,
13.3) were lost by 10 years as compared to 35.5 percent
(24.8, 49.2) of foreign born participants. No significant
difference was seen across gender. Only 148 (6.1 percent)
of the 2417 children with an SSN on file at the time of the
NDI submission were lost to follow-up before 10 years,
whereas 362 (17.2 percent) of the 2,105 without an SSN
were lost. Since the date of SSN acquisition was not
recorded, however, this precluded proper assessment of its
effect as a time-dependent covariate on reducing loss to
follow-up.
Conclusion
Three factors were independently associated with a low-
ered NDI match rate among known decedents: lack of
SSN, Hispanic ethnicity and birth outside the US. Using
NWTS mortality rates we estimated that 79.3 deaths
should have occurred among subjects lost to follow-up yet
only 18 such deaths were ascertained by the NDI search.
We conclude that, in populations such as ours that are
actively followed, the NDI cannot be used to reliably fill
in missing follow-up data and that doing so may lead to
inflated survival estimates.Epidemiologic Perspectives & Innovations 2007, 4:5 http://www.epi-perspectives.com/content/4/1/5
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To the best of our knowledge this was the first study
designed to evaluate the NDI as a means of substituting
for follow-up data in children and young adults. In the
NWTS cohort, over 70 percent of deaths occurred before
age 10. The bulk of missing follow-up time was while sub-
jects were between 10 and 30 years of age. Several previ-
ous studies have used the NDI in similar populations but
either lacked their own follow-up data or did not use it as
a means of assessing the NDI [15-17,32].
The sensitivities of an NDI match observed for subjects
with and without an SSN on file, 97 percent and 88 per-
cent, are within the range of match rates found in previous
studies of adults [8]. During the early years of the study
parents were unlikely to have applied for SSNs for their
young children. SSNs were not routinely requested for
subjects on the NWTS late effects and therapeutic studies
until 1979 and 1986, respectively. Our finding that chil-
dren with an SSN on file had lower rates of loss is in part
a statistical artifact, caused by the fact that SSNs were
requested by parents and ascertained by the NWTS
Breakdown of NWTS* cohort by January 1, 2002 vital status and NDI* match status Figure 1
Breakdown of NWTS* cohort by January 1, 2002 vital status and NDI* match status. 
* NWTS, National Wilms Tumor Study; NDI, National Death Index. 
† Record not sent to the NDI due to an error in date last seen which was later corrected.
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Table 1: NDI* match counts by January 1, 2002 vital status as ascertained in April 2005
January 1, 2002 vital status ascertained in April, 2005 from NWTS* records
Dead Alive Unknown Total (%)
NDI* 1970–1978 1979–2001
Match 0 709 0 18 727 (11.7)
No Match 198 80 1,052 2,333 3,663 (58.9)
Not sent 0 0 1,826 1† 1,827 (29.4)
Total (%) 198 (3.2) 789 (12.7) 2,878 (46.3) 2,352 (37.8) 6,217 (100.0)
* NDI, National Death Index; NWTS, National Wilms Tumor Study.
† Record not sent to the NDI due to an error in date last seen which was later correctedEpidemiologic Perspectives & Innovations 2007, 4:5 http://www.epi-perspectives.com/content/4/1/5
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throughout the study, so those with longer periods of fol-
low-up would have had more opportunity to get an SSN.
Parents or adult subjects who report SSNs may also be eas-
ier to track for other reasons. Nonetheless, the message is
clear that studies with a mortality end-point that antici-
pate long follow-up periods or a high potential for study
drop out should endeavor to collect SSNs both to facilitate
tracking and to increase the effectiveness of any future
NDI search.
One recent study based on active follow-up of Hispanics
over age 65 suggested that NDI linkage rates may under-
ascertain deaths in this population [33]. While the results
of this study are under review and may have been over-
stated [34] , our results demonstrate the same phenome-
non for young Hispanic subjects. A small portion of the
under-ascertainment in adults has been attributed to
"salmon bias", the likelihood that foreign born subjects
will return home to their country of origin once they
become ill [33]. A small portion of the under-ascertain-
ment in our pediatric population was likewise attributable
to the low (56.5 percent) match sensitivity observed for
subjects known to be foreign born (n = 23), many of
whom presumably returned home once treatment was
completed.
Dividing 18 by 79.3 gives an expected match rate (22.7
percent) for the presumably deceased subjects that is
much lower than the match rate observed for known
decedents (89.9 percent). Part of this discrepancy could be
due to bias in NWTS rates, for example, the "bad news
travels fast" principle such that deaths are reported in pref-
erence to the fact that the subject is alive and well. In this
case NWTS death rates would be overestimated. Most of
the discrepancy, however, is likely due to very substantial
under-ascertainment by the NDI of the deaths that pre-
Table 3: Estimated survival at 15 years from diagnosis calculated using follow-up from NWTS* records only†, NWTS records 
supplemented with NDI* search results and NDI search results only
NWTS only NWTS + NDI NDI only
Total Died % Alive 95% CI* Died % Alive 95% CI Died % Alive 95% CI
NWTS-1,2 1,310 317 77.8 (75.4, 79.9) 322 78.1 (75.8, 80.2) 307 79.0 (76.7, 81.1)
NWTS-3,4 4,907 670 85.7 (84.6, 86.7) 683 86.0 (85.0, 87.0) 618 87.4 (86.4, 88.3)
* NWTS, National Wilms Tumor Study; NDI, National Death Index; CI, confidence interval.
† April 2005 ascertainment of January 1, 2002 vital status.
Table 2: Demographic characteristics and NDI* match counts of the known decedents (1979–2001) as ascertained in April 2005
Total Match % Match OR*† 95% CI*†
Sex
Female 413 364 88.1 1.00
Male 376 345 91.8 1.49 (0.90, 2.48)
Ethnicity
Caucasian, non-Hispanic 551 507 92.0 1.00
African American 147 131 89.1 0.67 (0.35, 1.25)
Asian 13 12 92.3 1.19 (0.13, 11.10)
Hispanic 72 55 76.4 0.30 (0.14, 0.63)
Unknown/Other 6 4 66.7 0.31 (0.05, 1.99)
SSN
Unknown 606 532 87.8 1.00
Known 183 177 96.7 4.04 (1.54, 10.58)
Place of birth
United States 623 568 91.2 1.00
Foreign 23 13 56.5 0.12 (0.04, 0.34)
Unknown 143 128 89.5 1.02 (0.54, 1.94)
Age at death
0–4 years 245 231 90.9 1.00
5–9 years 329 291 88.4 0.61 (0.33, 1.10)
10–19 years 156 141 90.4 0.60 (0.28, 1.32)
20+ years 50 46 92.0 0.35 (0.09, 1.37)
Total 789 709 89.9
* NDI, National Death Index; OR, odds ratio; CI confidence interval.
† Odds ratios and 95 percent confidence intervals adjusted for sex, ethnicity, presence of SSN, year of death, location of birth, age at death group, 
location of treatment institution, institutional compliance and NWTS recorded cause of death.Epidemiologic Perspectives & Innovations 2007, 4:5 http://www.epi-perspectives.com/content/4/1/5
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sumably occurred in this group of subjects during the
period they were lost to follow-up.
Factors associated with a loss of contact by the NWTS,
such as emigration from the US, are also associated with a
lower probability of an NDI match in case of death. In
other words, dropout is subject to the same selection bias
factors as the failure of the NDI to match a death. This was
demonstrated here for two factors on which information
was available: Hispanic ethnicity and foreign birth. It is
undoubtedly true also for other non measured and intan-
gible factors. The results of our analysis suggest that rely-
ing solely on NDI search results in this situation would
bias survival estimates upward.
This study serves as a reminder that subjects who are lost
to follow-up are highly selected on factors related to our
ability to maintain contact with them. Whether or not
they are also selected on the factor that counts most, their
likelihood of survival relative to that of subjects who
remain in follow-up, is in principle unknowable without
a perfect ascertainment system. While an NDI search can
often substitute for extensive and expensive mortality fol-
low-up, studies that actively maintain their own reasona-
bly good contacts with participants may not benefit from
using the NDI to substitute for follow-up in subjects with
whom they have lost contact. The cost of performing an
NDI search may not be justifiable. Nonetheless, our study
will benefit substantially from the NDI search since we
employed the optional NDI Plus service that provides the
cause of death codes found on death certifications sup-
plied to the NDI by the states. This greatly reduced the
work required to ascertain official causes of death since
death certificates for unmatched decedents must be
requested directly from the states. Work is currently in
progress on a comprehensive analysis of mortality in sur-
vivors of Wilms tumor that will include a comparison of
cause-specific death rates to those in the general popula-
tion.
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